PHAT

Phathom Pharmaceuticals, Inc. Common Stock

13.66

USD

PHAT Earnings Reports

Positive Surprise Ratio

PHAT beat 14 of 25 last estimates.

56%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

$57.96M

-$0.39

Implied change from Q3 25 (Revenue/ EPS)

+17.08%

-4.88%

Implied change from Q4 24 (Revenue/ EPS)

+95.39%

-62.86%

Phathom Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Oct 30, 2025, PHAT reported earnings of -0.41 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 26.25% surprise. Revenue reached 49.50 million, compared to an expected 47.93 million, with a 3.28% difference. The market reacted with a -1.63% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.39 USD, with revenue projected to reach 57.96 million USD, implying an decrease of -4.88% EPS, and increase of 17.08% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

FAQ

What were Phathom Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Phathom Pharmaceuticals, Inc. Common Stock reported EPS of -$0.41, beating estimates by 26.25%, and revenue of $49.50M, 3.28% above expectations.

How did the market react to Phathom Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -1.63%, changed from $13.53 before the earnings release to $13.31 the day after.

When is Phathom Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for Phathom Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 11 analysts, Phathom Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.39 and revenue of $57.96M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.